Reaction
Central Nervous System Leukaemia reporting signals
As of the last recalculation, Central Nervous System Leukaemia appears in 375 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 2,069.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 191 | 2,069.7 | 2,108.5 |
| Cytarabine | 49 | 51.9 | 52.0 |
| Dasatinib | 27 | 43.4 | 43.4 |
| Imatinib | 11 | 35.6 | 35.7 |
| Nilotinib | 16 | 31.4 | 31.4 |
| Azacitidine For | 10 | 31.3 | 31.3 |
| Pegaspargase | 6 | 27.6 | 27.6 |
| Azacitidine | 14 | 27.2 | 27.2 |
| Thiotepa | 4 | 23.5 | 23.5 |